Conceived and designed the experiments: AS. Performed the experiments: AS UD GH AE PM TD SP AM AV SC SA. Analyzed the data: AS MG PK TS. Contributed reagents/materials/analysis tools: AS SP MG RB SS PK. Wrote the paper: AS.
Aggregation of unfolded proteins occurs mainly through the exposed hydrophobic surfaces. Any mechanism of inhibition of this aggregation should explain the prevention of these hydrophobic interactions. Though arginine is prevalently used as an aggregation suppressor, its mechanism of action is not clearly understood. We propose a mechanism based on the hydrophobic interactions of arginine.
We have analyzed arginine solution for its hydrotropic effect by pyrene solubility and the presence of hydrophobic environment by 1-anilino-8-naphthalene sulfonic acid fluorescence. Mass spectroscopic analyses show that arginine forms molecular clusters in the gas phase and the cluster composition is dependent on the solution conditions. Light scattering studies indicate that arginine exists as clusters in solution. In the presence of arginine, the reverse phase chromatographic elution profile of Alzheimer's amyloid beta 1-42 (Aβ1-42) peptide is modified. Changes in the hydrodynamic volume of Aβ1-42 in the presence of arginine measured by size exclusion chromatography show that arginine binds to Aβ1-42. Arginine increases the solubility of Aβ1-42 peptide in aqueous medium. It decreases the aggregation of Aβ1-42 as observed by atomic force microscopy.
Based on our experimental results we propose that molecular clusters of arginine in aqueous solutions display a hydrophobic surface by the alignment of its three methylene groups. The hydrophobic surfaces present on the proteins interact with the hydrophobic surface presented by the arginine clusters. The masking of hydrophobic surface inhibits protein-protein aggregation. This mechanism is also responsible for the hydrotropic effect of arginine on various compounds. It is also explained why other amino acids fail to inhibit the protein aggregation.
Understanding protein aggregation during refolding and expression of proteins in heterologous systems is an important area in basic research as well as in pharmaceutical industry. Protein aggregation is also thought to be associated with several disease processes. It is generally observed that proteins tend to aggregate during in vitro refolding of proteins when the denaturant is being removed
Arginine and proline have been consistently shown to be helpful in preventing protein aggregation due to heating, dilution or partial unfolding
The polarity of arginine solutions in 0.02 M sodium phosphate buffer, pH 7.4, (PB) was studied using pyrene solubility and ANS fluorescence characteristics. Pyrene, with its polarity sensing solubility is useful for such studies. Pyrene is sparingly soluble in water. Its solubility increases with the decrease in the polarity of the solvent. Arginine increased the solubility of pyrene in PB in a dose dependent manner (
(A) Pyrene solubility in presence of arginine. The solubility is expressed as fold-increase over the control (solubility in arginine/solubility in buffer). 1 mg pyrene was incubated in arginine solutions at the indicated concentrations at 25°C for 24 h. The absorbance of the supernatant solution was measured at 350 nm. The solubility increases in a dose dependent manner. (B) ANS fluorescence in the presence of arginine. The excitation wavelength was 400 nm and the emission intensity was scanned from 450 to 600 nm. With the increase in arginine concentration, the maximum emission wavelength of ANS (250 µM in PB) decreases (open circle) and relative fluorescence intensity increases (closed circle). (C) Temperature dependence of ANS fluorescence in the presence of 0.2 M arginine. The observed intensity is expressed as % of intensity at 25°C. The intensity decreases above 45°C.
Interaction of arginine with other molecules involves both its polar and non-polar moieties. Experimental evidences using model compounds show that 3–5 arginine molecules are required to bind one ANS molecule and the binding is cooperative
Electrospray mass spectroscopy of amino acids. The aqueous solutions amino acids at 0.2 M concentrations were used. (A) Arginine exhibits extensive noncovalent protonated clusters when dissolved in water, pH without adjustment was 10.5. (B) ([nArg]Na)+ and ([nArg]H2PO4)+ clusters are observed when arginine is dissolved in sodium phosphate buffer, pH 7.4. (C) Less extensive clustering is seen in acidic solutions at pH 1.0. (D) Increase in Rayleigh light scattering by arginine solution (in PB) is concentration dependent (filled circle) indicating supramolecular assembly. This assembly is temperature sensitive and collapses above 45°C (filled triangle).
Large molecular clusters in solution resemble crystalline state in the intermolecular interactions, orientation of the molecules, self-salvation, etc. Typically, amino acids orient themselves in a peptide-like fashion with N- and C-terminal groups at juxtapositions and the side chains protruding away on both sides
The hydrophobic environment on the arginine clusters enhanced the hydrotropy of pyrene and caused an increased intensity and a blue-shift in the fluorescence emission maximum of ANS. Arginine has been reported for its hydrotropic effect with wide ranging molecules such as fatty acids
(A) Reverse phase chromatography of Aβ1-42 peptide. 10 µg of peptide was chromatographed on the RPC C8 column (250×4.6 mm) in the presence and absence arginine. The peptide was eluted with 0–60% acetonitrile linear gradient in PB at a flow rate of 0.7 ml/h and monitored at 257 nm. The arrowhead indicates the start of the gradient. The profiles in the presence and absence of arginine are indicated. (B) Size exclusion chromatography. 10 µg of Aβ1-42 was chromatographed on SMART Superdex G-75 column with and without arginine. The monomeric and tetrameric forms of Aβ1-42 elutes with larger hydrodynamic volume in the presence of arginine (red curve) compared with the control (blue curve). (The molecular weights are indicated by arrows).
To mask the hydrophobic surfaces of Aβ1-42, the arginine has to bind to these surfaces. Arginine exists in clusters and these clusters have a hydrophobic surface. It is expected that arginine clusters bind to Aβ1-42. Under these conditions the hydrodynamic volume of Aβ1-42 should increase significantly. The size exclusion chromatographic experiments showed that the monomeric form of Aβ1-42 eluted with a mass corresponding to 6.0 kDa in the presence of 0.2 M arginine as compared to 4.5 kDa without arginine (
One of the consequences of interactions between Aβ1-42 and clusters of arginine molecules should be the increased hydrotropy of the peptide in presence of arginine as with pyrene and decreased aggregation as with proteins. We have determined the Aβ solubility and aggregation in the presence of various amino acids. Arginine and proline were the two amino acids that enhanced the solubility of Aβ1-42 significantly (
The amino acids are indicated by single letter code. Data are given as mean±SE of four experiments in duplicates with 0.2 M amino acids. Diagonal upward bar - 0.5 M proline; vertical bar - 1.0 M proline (mean of 2 experiments). With arginine, dark shade - 0.3 M arginine; diagonal downward bar - 0.4 M arginine; horizontal bar - 0.5 M arginine (mean of 2 experiments).
AFM images (3×3 micron). Aβ1-42 was incubated in PB at 25°C for 24 h. (A) Inhibition of aggregation of Aβ1-42 by 0.2 M arginine. (B) Inhibition of aggregation of Aβ1-42 by 0.2 M proline. (C) Complete solubilization of Aβ1-42 at pH 10.5. No fibrils were observed. (D) Control experiment in which the fibrils formed. (Inset) Transmission electron micrograph of 24 h control sample at higher magnification (22,000×) showing spherical aggregating units.
The aggregation of unfolded proteins and amyloid type proteins involve hydrophobic surfaces. In such cases, interactions of the hydrophobic surfaces provided by the clusters of arginine or proline would be more effective than the interaction between protein hydrophobic surface and an individual molecule of these two amino acids. Secondly, a hydrophobic surface of large dimensions cannot be maintained in an aqueous environment. The crystal structures of arginine and proline revealed the presence of hydrophobic columns along one of its crystallographic axis
Our results show that arginine presents a hydrophobic environment in solutions, exists in supramolecular assemblies and binds to Aβ1-42. This binding modulates the hydrophobicity of Aβ1-42 molecule and suppresses fibrillar formation.
Mouse Aβ1-42, DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAII GLMVGGVVIA was synthesized using Fmoc chemistry on an automated peptide synthesizer (model PS3, Protein Technologies, USA). The peptide was purified on a ProRPC C-18 column in a FPLC system. The peptide was stored at −20°C as lyophilized powder. Before use, the peptide was dissolved in 0.01 M NaOH and centrifuged at 16,000 g for 10 min at 4°C.
The solubility of pyrene was measured at various concentrations of arginine. Arginine at indicated concentrations in PB was incubated with 1 mg of pyrene at 25°C for 24 h. The solutions were centrifuged at 16,000 g for 15 min at 25°C. The absorbance of the supernatant was measured at 350 nm.
The changes in the emission wavelength maximum and fluorescence intensity of 1-anilino-8-naphthalene sulfonic acid (ANS) were measured in the presence of various concentrations of arginine, lysine, methionine and leucine in PB at 25°C. The fluorescence measurements were made using a Varian Cary Eclipse fluorescence spectrophotometer (Varian, USA). The excitation was at 400 nm and the emission spectra were recorded from 450–600 nm with a bandwidth of 5 nm. Blanks contained only the amino acids at the corresponding concentrations.
The temperature dependence of ANS fluorescence in presence of 0.2 M arginine were measured by changing the cuvette temperature by circulating water, maintained at different temperatures with an accuracy of ±0.1°C. The cuvettes were allowed to thermally equilibrate for 5 min before taking the reading.
The amino acid solutions were prepared in MilliQ water and the pH was adjusted with dilute H3PO4 or PB. The concentration of the amino acid was 0.2 M. All mass spectra were obtained using a nanospray ESI-Q-TOF mass spectrometer (QStar XL, Applied Biosystems Inc., USA). The signal was tuned on the protonated dimer of arginine clusters. Tuning on higher-order clusters did not result in either the signal strength or change in the distribution of clusters. The settings used in this study were as follows: curtain gas flow 0.70 ml/min; the ion spray voltage 900 V; the declustering potentials DP1 100 V and DP2, 12 V; the focusing potential 100 V. The positive ion spectra were obtained for 5 min in acquire mode. Protonated dimers and trimers always appeared along with protonated monomers.
Rayleigh scattering of 400 nm light was measured at 90° geometry on a Jasco J-810 spectrometer fitted with a Jasco FMO427 fluorescence emission monochromator attachment. The excitation monochromator was set at 400 nm and the emission was scanned between 385 nm and 410 nm, with the bandpass set at 10 nm for both monochromators. For room temperature measurements, five scans were performed for each sample and the measurement at 400 nm was noted and averaged. Arginine solutions were prepared in PB at indicated concentrations. Triplicate samples were used at each concentration. Similarly, for measurements at different temperatures, the peltier attachment of the spectrometer was set to the desired temperature before the performance of the five scans.
The Aβ1-42 peptide was dissolved in 0.01 M NaOH and centrifuged at 16,000 g for 10 min at room temperature. The pH was adjusted to 7.4 by the addition of PB with and without 0.2 M arginine. The final concentration of the peptide was 200 µg/ml. The solutions were incubated for 3 h at room temperature. 0.05 ml of the solution was loaded on to the RPC C8 column (250×4.6 mm) (Phenomenex, USA) equilibrated with PB using a Shimadzu HPLC set up (Model SCL-10 AVP, Shimadzu, Japan). A linear gradient of acetonitrile from 0% to 60% in 30 min was applied at a flow rate of 0.7 ml/min. For the treated sample, the equilibration and elution buffers contained 0.2 M arginine. The sample was monitored at 257 nm.
Chromatography was performed on a SMART analytical Superdex G75 column on a SMART system from Amersham Pharmacia (30 cm length, bed volume 2.4 ml) using a flow rate of 100 µl/min and with monitoring of absorption of elution carried out at 257 nm (corresponding to the absorption of phenylalanine). The column was equilibrated with PB or with PB containing 0.2 M arginine before loading of peptide samples (10 µg in 50 µl). The peptide was incubated for 1 h with 0.2 M arginine before loading.
The L-amino acids (Sigma Chemical Co., USA) in 10 mM phosphate buffer, pH 7.4 (PB) were added to alkali-solubilized Aβ1-42 to give a final concentration of 0.2 M amino acids and 10 µM Aβ1-42. After 30 min incubation at 25°C, the tubes were centrifuged at 16,000 g for 15 min. The supernatant was made alkaline by the addition of 0.05 M NaOH. The absorbance at 257 nm was read for the supernatant fractions (Lambda 25 model, Perkin Elmer, USA). The absorbance was compared with the 10 µM Aβ1-42 in 0.01 M NaOH. 0.2 M solutions of tyrosine, tryptophan, glutamic acid and phenylalanine could not be prepared due to their insolubility in PB.
All images were obtained in the MAC mode to ensure minimum sample damage using a PicoSPM equipment (Molecular Imaging, USA). AuCr coated MAC cantilevers, 225 µm long, resonance frequency of 83 kHz and force constant of 2.8 N/m were used for imaging. Scan speed used in was 1 line/sec. 2 µl of 10 µM Aβ1-42 solution with and without 0.2 M amino acids was deposited on a freshly cleaved piece of mica (1×1 cm) and allowed to stand for 2 min. Imaging was carried out in air. Minimum image processing (first order flattening and brightness contrast) was used.
Aβ1-42 at 10 µM concentration in PB was incubated for 24 h at 25°C. The samples were agitated gently before being spotted on a 400-mesh carbon-coated EM grid for two minutes and stained with 1% uranyl acetate for 1 min. Micrographs were recorded using transmission electron microscope (Morgagni 268D, FEI-Philips, USA).
The coordinates were taken from Karle and Karle
Mass spectra of methionine, lysine, leucine and proline. 0.2 M solutions in PB were used. The scan conditions were the same as used for arginine (
(9.27 MB TIF)
Click here for additional data file.
The crystal packing of arginine molecule shown in sphere model. The yellow color indicates the hydrophobic regions of arginine and the solvent molecules were shown in orange color. The coordinates were taken from Karle and Karle (see ref) and visualized using the program Mercury (Version 1.4). The view is along the b-axis.
(0.17 MB TIF)
Click here for additional data file.
AFM images of Aβ1-42 in the presence of 0.2 M amino acids. (A) methionine after 24 h; (B) leucine after 24 h; (C) lysine after 24 h. (D) arginine after 48 h. Only arginine prevents Aβ1-42 aggregation significantly. Legend as in the
(2.45 MB TIF)
Click here for additional data file.
ANS fluorescence in presence of arginine, methionine, lysine and leucine. The excitation wavelength was 400 nm. ANS fluorescent intensity was measured at the emission λmax for the respective amino acids at different concentrations. ANS was present at 250 µM concentration. The amino acids of respective concentration formed the control. Legend as in
(8.49 MB TIF)
Click here for additional data file.
We thank Dr. P. Guptasarma, Institute of Microbial Technology, Chandigarh for discussion and for access to light scattering and size-exclusion chromatographic systems in his laboratory. UD, ASE and MG acknowledge the financial help from Council for Scientific and Industrial Research, Government of India. PM acknowledges Indian Council of Medical research, Government of India for financial help.